Jaguar Health, Inc. (NASDAQ:JAGX – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.18 and traded as high as $1.19. Jaguar Health shares last traded at $1.14, with a volume of 309,156 shares trading hands.
Wall Street Analyst Weigh In
Separately, StockNews.com raised shares of Jaguar Health from a “sell” rating to a “hold” rating in a report on Friday, September 13th.
View Our Latest Stock Analysis on JAGX
Jaguar Health Stock Performance
Jaguar Health (NASDAQ:JAGX – Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($4.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.20) by ($2.84). The business had revenue of $2.72 million for the quarter. Jaguar Health had a negative return on equity of 412.63% and a negative net margin of 350.18%. Sell-side analysts forecast that Jaguar Health, Inc. will post -0.78 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Jaguar Health
A hedge fund recently bought a new stake in Jaguar Health stock. Perritt Capital Management Inc acquired a new stake in shares of Jaguar Health, Inc. (NASDAQ:JAGX – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 25,000 shares of the biotechnology company’s stock, valued at approximately $90,000. Perritt Capital Management Inc owned approximately 0.51% of Jaguar Health as of its most recent SEC filing. 12.04% of the stock is owned by institutional investors.
About Jaguar Health
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.
Read More
- Five stocks we like better than Jaguar Health
- Pros And Cons Of Monthly Dividend Stocks
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Business Services Stocks Investing
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Best Stocks Under $5.00
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.